Cargando…

Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population

PURPOSE: Nonadherence to indicated therapy reduces treatment effectiveness and may increase cost of care. HUMIRA Complete, a Patient Support Program (PSP), aims to reduce nonadherence in patients prescribed adalimumab (ADA). The objective of this study was to assess the relationship between particip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brixner, Diana, Mittal, Manish, Rubin, David T, Mease, Philip, Liu, Harry H, Davis, Matthew, Ganguli, Arijit, Fendrick, A Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750846/ https://www.ncbi.nlm.nih.gov/pubmed/31571837 http://dx.doi.org/10.2147/PPA.S215037

Ejemplares similares

Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit
por: Fendrick, A Mark, et al.
Publicado: (2021)

Higher Medication Adherence and Lower Opioid Use Among Individuals with Autoimmune Disease Enrolled in an Adalimumab Patient Support Program in the United States
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Impact of Online Prescription Management Systems on Biologic Treatment Initiation
por: Hawkes, Jason E., et al.
Publicado: (2019)

Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Adalimumab in the treatment of arthritis
por: Mease, Philip J
Publicado: (2007)

The Rise of Prescription Digital Therapeutics in Behavioral Health
por: Brezing, Christina A., et al.
Publicado: (2022)

An Ambulatory Care Clinic and Community Pharmacy Collaboration to Address Prescription Abandonment
por: Gaborcik, Joshua W., et al.
Publicado: (2019)

Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
por: Mease, Philip, et al.
Publicado: (2015)

Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications
por: Gleason, Patrick, et al.
Publicado: (2009)

Impact of Pharmacist-Led PDCA Cycle in Reducing Prescription Abandonment: An Action Research from China
por: Lv, Lisong, et al.
Publicado: (2023)

Abandoned Intracardiac Electrodes in an Oncological Patient
por: Klotzka, Aneta, et al.
Publicado: (2023)

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
por: Jiang, Yijia, et al.
Publicado: (2023)

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
por: Mease, P J, et al.
Publicado: (2008)

Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
por: Menter, Alan, et al.
Publicado: (2017)

Hope abandoned : a memoir
por: Mandelʹshtam, Nadezhda, 1899-1980

Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab
por: Rissel, Florian, et al.
Publicado: (2023)

Nunca me abandones
por: Ishiguro, Kazuo, 1954-
Publicado: (2010)

Nunca me abandones
por: Ishiguro, Kazuo, 1954-

Abandoning Eugenics and the QALY
por: Langley, Paul C
Publicado: (2021)

The Care of Abandoned Children
Publicado: (1870)

Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone
por: Ben-Joseph, Rami, et al.
Publicado: (2016)

How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis
por: Martora, Fabrizio, et al.
Publicado: (2023)

Reconsidering patient‐centred care: Authority, expertise and abandonment
por: Pilnick, Alison
Publicado: (2023)

Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
por: Strand, Vibeke, et al.
Publicado: (2017)

Population Dynamics and Flight Phenology Model of Codling Moth Differ between Commercial and Abandoned Apple Orchard Ecosystems
por: Joshi, Neelendra K., et al.
Publicado: (2016)

Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis
por: Betts, Keith A., et al.
Publicado: (2016)

Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
por: Ding, Xiaoliang, et al.
Publicado: (2020)

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
por: Sieper, Joachim, et al.
Publicado: (2013)

Weapons abandoned in favour of detectors
Publicado: (2000)

The abandoned children of the Islamic State
por: The Lancet Child & Adolescent Health
Publicado: (2020)

Abandon “Race.” Focus on Racism
por: Braveman, Paula, et al.
Publicado: (2021)

Oral Anticoagulant Therapy in Patients Receiving Haemodialysis: Is It Time to Abandon It?
por: Saracyn, Marek, et al.
Publicado: (2013)

Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
por: Strand, Vibeke, et al.
Publicado: (2021)

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry
por: Loftus, Edward V, et al.
Publicado: (2019)

Real‐life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
por: Kapoor, Sanjiv, et al.
Publicado: (2019)

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study
por: Van den Bosch, Filip, et al.
Publicado: (2017)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
por: Sohn, Il Woong, et al.
Publicado: (2016)

Adalimumab for severe psoriasis in Chilean paediatric patients()()
por: Armijo Fernandez, Daniela, et al.
Publicado: (2020)

Ulcerative Tuberculosis in a Patient Treated with Adalimumab
por: VARPULUOMA, Outi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1s8133j132hl2ogbfmguk6c0e7